Herbalife (NYSE:HLF) Upgraded at Zacks Research

Zacks Research upgraded shares of Herbalife (NYSE:HLF) from a hold rating to a strong-buy rating in a research note released on Thursday,Zacks.com reports.

A number of other research firms have also recently commented on HLF. Weiss Ratings restated a “hold (c)” rating on shares of Herbalife in a research report on Thursday, January 22nd. Maxim Group initiated coverage on shares of Herbalife in a report on Tuesday, January 6th. They issued a “buy” rating and a $20.00 price target for the company. Citigroup reaffirmed a “buy” rating and set a $21.00 price objective (up from $17.00) on shares of Herbalife in a report on Thursday. Wall Street Zen raised shares of Herbalife from a “hold” rating to a “buy” rating in a research note on Friday, November 28th. Finally, Argus set a $15.00 price target on shares of Herbalife in a research report on Wednesday, November 26th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, Herbalife presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.60.

Herbalife Stock Performance

Shares of Herbalife stock opened at $19.92 on Thursday. The firm has a 50-day simple moving average of $15.60 and a two-hundred day simple moving average of $11.74. Herbalife has a fifty-two week low of $6.20 and a fifty-two week high of $20.34. The company has a market cap of $2.06 billion, a P/E ratio of 9.05 and a beta of 0.84.

Herbalife (NYSE:HLF) last announced its quarterly earnings results on Wednesday, February 18th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.48 by ($0.03). The business had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.24 billion. Herbalife had a net margin of 4.53% and a negative return on equity of 35.02%. Herbalife’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.36 EPS. Equities research analysts forecast that Herbalife will post 1.57 EPS for the current year.

Hedge Funds Weigh In On Herbalife

Several hedge funds and other institutional investors have recently modified their holdings of HLF. Optimize Financial Inc grew its stake in Herbalife by 1.5% during the 4th quarter. Optimize Financial Inc now owns 61,426 shares of the company’s stock valued at $792,000 after acquiring an additional 880 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Herbalife by 7.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,176 shares of the company’s stock worth $200,000 after purchasing an additional 933 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Herbalife by 3.4% in the second quarter. The Manufacturers Life Insurance Company now owns 36,642 shares of the company’s stock valued at $316,000 after purchasing an additional 1,217 shares in the last quarter. CWM LLC increased its holdings in shares of Herbalife by 5.9% in the fourth quarter. CWM LLC now owns 24,229 shares of the company’s stock valued at $312,000 after purchasing an additional 1,348 shares during the last quarter. Finally, Harbor Capital Advisors Inc. lifted its position in Herbalife by 8.9% during the fourth quarter. Harbor Capital Advisors Inc. now owns 16,488 shares of the company’s stock worth $213,000 after buying an additional 1,351 shares in the last quarter.

More Herbalife News

Here are the key news stories impacting Herbalife this week:

• Positive Sentiment: Cristiano Ronaldo purchased a disclosed minority stake (reported as ~10% of the Pro2col unit), which investors have treated as a credibility and growth signal for Herbalife’s wellness/tech spinout. Cristiano Ronaldo Invests $7.5 Million Into Herbalife—Stock Surges
• Positive Sentiment: Q4 revenue (≈$1.28–1.30B) topped consensus and the company issued FY/quarter guidance in line with or slightly above Street expectations — supporting the view that top-line growth is intact. Herbalife (NYSE:HLF) Beats Q4 CY2025 Sales Expectations, Stock Jumps 11.7%
• Positive Sentiment: Analysts and quant-rank services turned more constructive: Maxim reiterated a Buy and Zacks added HLF to its Rank #1 (Strong Buy) lists, boosting short-term demand from retail and model-driven funds. Buy Rating on Herbalife Driven by Turnaround Momentum… New Strong Buy Stocks for February 20th
• Positive Sentiment: Shares hit a 52-week / multi-year high on the combined impact of the deal news, better-than-expected net sales and increased volume — momentum that can attract momentum/trend traders. Herbalife (HLF) Climbs to 3-Year High on Net Sales Beat
• Neutral Sentiment: The full Q4 earnings call transcript and slide deck are available for investors who want detailed color on product innovation, distributor trends and digital personalization initiatives — useful for modeling longer-term growth but not an immediate catalyst by itself. Herbalife Q4 2025 earnings call transcript
• Negative Sentiment: Mixed profitability signals: while revenue and operating cash flow grew, reported EPS metrics missed some consensus figures and the company showed year-over-year declines in operating profit and net income, which raises questions about margin recovery. Herbalife Ltd. (HLF) stock rises on Q4 2025 Earnings
• Negative Sentiment: Some outlets flagged an EPS miss versus consensus and a negative ROE / thin net margin — fundamentals investors watch for sustained valuation support. Herbalife Ltd (HLF) Misses Q4 Earnings and Revenue Estimates

About Herbalife

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.